Memphis, TN13 Active Studies

Ankylosing Spondylitis Clinical Trials in Memphis, TN

Find 13 actively recruiting ankylosing spondylitis clinical trials in Memphis, TN. Connect with local research sites and explore new treatment options.

13
Active Trials
5
Sponsors
2,692
Enrolling

Recruiting Ankylosing Spondylitis Studies in Memphis

About Ankylosing Spondylitis Clinical Trials in Memphis

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 13 ankylosing spondylitis clinical trials recruiting participants in Memphis, TN. These studies are seeking a combined 2,692 participants. Research is being sponsored by Children's Hospital Los Angeles, RTI International, St. Jude Children's Research Hospital and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Memphis — FAQ

Are there ankylosing spondylitis clinical trials in Memphis?

Yes, there are 13 ankylosing spondylitis clinical trials currently recruiting in Memphis, TN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Memphis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Memphis research site will contact you about next steps.

Are clinical trials in Memphis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Memphis studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 13 active trials in Memphis are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 18, 2026 from ClinicalTrials.gov